Back to ArticlesThe Carcino Foundation
13 min read•Sep 25, 2026

Thyroid & Parathyroid Cancer: Endocrine Tumors, Hypercalcemia, Thyroidectomy & RAI

S

Soushree Chakraborty | Chief Research Officer

Carcino Research & Clinical Advisory

Thyroid cancer and parathyroid cancer are distinct endocrine gland malignancies in the neck with contrasting physiological impacts, hormone secretions, and treatment approaches.

Hormones Secreted & Regulation

Thyroid Hormones: T3 & T4 (follicle cells regulate metabolic rate), Calcitonin (C-cells lower blood calcium). TSH pituitary regulation.

Parathyroid Hormone: PTH (chief cells raise blood calcium by bone release & kidney reabsorption).

Thyroid Cancer: Types & Treatments

• Papillary Thyroid Cancer (~80%): Slow-growing, excellent prognosis (>98% 5-yr survival).

• Follicular Thyroid Cancer (~10%): Linked to low iodine, blood-borne metastasis.

• Medullary Thyroid Cancer (MTC <5%): Calcitonin C-cell origin, MEN2 genetic link.

• Anaplastic Thyroid Cancer (<1%): Extremely aggressive and rapidly invasive.

Symptoms: Painless neck lump, hoarseness, dysphagia, neck pain, swollen nodes.

Treatment: Total Thyroidectomy, Radioactive Iodine (RAI I-131), lifelong levothyroxine hormone replacement.

Parathyroid Cancer & Severe Hypercalcemia

Parathyroid Carcinoma is an extremely rare malignancy (<100 cases/yr US) causing severe PTH overproduction.

Symptoms: Severe Hypercalcemia (>14 mg/dL), extreme fatigue, bone pain/fractures, kidney stones, polyuria/thirst, nausea, neck lump.

Treatment: En bloc surgical resection removing parathyroid gland & adjacent tissue. Chemotherapy and radiation are ineffective.

Frequently Asked Questions (FAQs)

Citations & Medical References